A series of 12 videos to offer practical Parkinson’s advice
Resources & Tools
Author: Parkinson's Life editorsPublished: 19 May 2016
Prep: Cook: Serves:
Imagine if you had an extra hour for doing good. A new video project shows the Parkinson’s community what can be achieved in just one hour more
What could you achieve if you had one hour more each day? If you’re living with Parkinson’s an extra hour of ‘on time’ could really improve your quality of life.
A new series of 12 short illustration videos shows what you can do to during your ‘on time’ to help specific aspects of living with Parkinson’s. The videos, developed as part of ‘1 hour more’, are released on the project’s Facebook page every two weeks and aim to offer both emotional and practical support.
Matteo Brambilla, ‘1 hour more’ project manager, said: “Parkinson’s stories can and should be engaging: if a picture is ‘worth a thousand words’ then a moving image can be even more thrilling, and can help cultivate and increase awareness of Parkinson’s”.
Don’t be afraid to ask for help
The first in the series is titled ‘companionship’. The key message of the video is that spending time with good friends can positively affect your mindset.
Maintaining a routine inspires new adventures
The second video focuses on the importance of regular sleeping cycles and medication routines. The ‘1 hour more’ Facebook posts accompanying this video offer tips such as: “Keep an eye on times so that the pills work as efficiently as possible, allowing you to manage your schedule in a calm, stress-free and optimal way.”
Joining a choir can strengthen your voice
Living with Parkinson’s can affect your voice, which can sometimes make communication challenging. The third video in this series gives some tips on activities to improve the strength of your voice.
About ‘1 hour more’
The ‘1 hour more’ project invites people with Parkinson’s to submit their personal stories, which are published on a bespoke digital platform. The stories in the collection focus on the value of ‘time’ for all people within the Parkinson’s community and aim to raise public awareness of the condition. The project launched a series of video animations to inspire people with Parkinson’s to lead a full life.
To view the project so far visit the ‘1 hour more’ website
Parkinson’s gene therapy could improve motor symptoms
UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s. The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences. The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function. Professor Thomas Foltynie, neurology consultant at University College London Hospitals – which is carrying out the research alongside University College London – said: “Genes that increase the production of dopamine could help alleviate the symptoms of Parkinson’s disease, potentially with fewer side effects than traditional drug treatments, by targeting only the areas of the brain that are lacking in dopamine.”
Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs
Pharmaceutical company Pfizer has teamed with investment firm Bain Capital to launch Cerevel Therapeutics – a biopharmaceutical company focused on developing drugs for Parkinson’s and other central nervous system conditions. The new company – which will receive US $350 million of investment from Bain Capital – will begin working on phase three clinical trials on a Parkinson’s drug designed to increase levels of dopamine in the brain. Cerevel will also continue to develop several of Pfizer’s drug programmes which closed earlier this year. Marco Baptista, director of research programmes at The Michael J Fox Foundation – which has partnered with Pfizer since 2010 – said: “This is welcome news for Parkinson’s patients and researchers. Pfizer had developed a diverse group of novel therapeutics for Parkinson’s disease, which are now going to get another chance at success. MJFF looks forward to partnering with Cerevel to support the advancement of these promising…
AI technology could diagnose Parkinson’s in less than three minutes
Chinese technology enterprise Tencent has partnered with UK healthcare company Medopad and the Centre of Excellence in Parkinson’s and Movement Disorders at Kings College Hospital, UK, to create artificial intelligence (AI) software that may be able to diagnose Parkinson’s in less than three minutes. The team trained the AI system by analysing video footage of people with Parkinson’s, and believes it will help doctors identify and diagnose the condition at a far earlier stage. In addition, it is hoped the test could be carried out remotely using smartphone technology. Dan Vahdat, CEO and Co-founder of Medopad, said: “Our partnership with Tencent comes from a shared vision to change the future of healthcare as we know it. “In combining Medopad’s medical expertise and Tencent’s technical capabilities, we hope to provide the technology needed to support clinicians to predict preventable complications for people with Parkinson’s disease.”